ADTRALZA
ADTRALZA
Approved
DIN Number
02540193
Drug Class
Human
Market Date
Jun 3, 2024
Company
HC
LEO Pharma Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02540193
AIG Number0163195001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
D11AH07 TRALOKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRALOKINUMABActive
Strength: 300 MG / 2 ML
Monograph: TRALOKINUMAB